We are powering the T-cell receptor (TCR) complex to provide more than just hope to cancer patients and a fundamental change for what it means to be diagnosed with solid tumors and hematologic malignancies.
Our TRuC-T cells are redefining the cell therapy landscape by harnessing the most powerful part of your immune system designed by evolution – the T-cell – directing it to specifically and sustainably attack your cancer.
- Our Clinical Trials
- Our Commitment
At TCR2, passion for patients is everything. Our Chief Executive Officer, Dr. Garry Menzel, wrote this letter on behalf of all of us to tell you how much you mean to us, and how we’re working every day to help.